Informations générales (source: ClinicalTrials.gov)

NCT01390532 Statut inconnu
Left Ventricular Dyssynchrony: Rest/Stress 3D Blood-Pool Gated D-SPECT Quantification With a High-Speed Dedicated Cardiac Camera Before CRT
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
août 2010
octobre 2011
29 juin 2024
Cardiac Resynchronization Therapy (CRT) is an established treatment for patients with advanced heart failure and left ventricular dyssynchrony (LVD). Too many patients do not clinically improve with CRT. New LVD markers other than QRS duration are needed. Study objective : feasibility assessment of rest and real-time stress 3D Blood-Pool Gated SPECT (BPGS) with a new designed cardiac imaging camera (DSPECT, Spectrum Dynamics®, Ceasaria, Israel) to quantify LVD.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHU de CLERMONT-FERRAND - Clermont-Ferrand - France Patrick LACARIN En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

Chronic heart failure with LVEF < 35 %, QRS > 120 ms, NYHA III/IV, optimal medical
therapy for more than one month.

- Patient with stable hemodynamic for more than one month,

- More than 18-year old man or woman,

- Patient having given his free, inform and signed consent,

- Patient place setting by the social security system,


- Psychiatric disorder

- Any contra-indication to Technetium,

- Any contra-indication to dobutamin or atropin

- Personal or family history of sudden death

- Previous severe ventricular arrhythmia

- Obstructive cardiomyopathy, severe aortic stenosis,

- Pulmonary hypertension,

- History of renal, lung, hepatic, cardiac transplantation,

- Pregnant or breast-feeding Woman,

- Patient who can not conform to the requirements of the protocol,

- Patient included in another medical study,